FRAX: a coming of age

Zurück zum Zitat Kanis JA, Johansson H, Harvey NC, McCloskey EV. A brief history of FRAX. Arch Osteoporos 2018;[epub] Kanis JA, Johansson H, Harvey NC, McCloskey EV. A brief history of FRAX. Arch Osteoporos 2018;[epub]

Zurück zum Zitat Johansson H, Azizieh F, Al Ali N, Alessa T, Harvey NC, McCloskey E et al (2017) FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int 28:3099–3105CrossRef Johansson H, Azizieh F, Al Ali N, Alessa T, Harvey NC, McCloskey E et al (2017) FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int 28:3099–3105CrossRef

Zurück zum Zitat Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV et al (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25CrossRef Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV et al (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25CrossRef

Zurück zum Zitat Kanis JA. Assessment of osteoporosis at the primary health-care level. Technical Report. Accessible at http://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf. Published by the University of Sheffield; 2007 Kanis JA. Assessment of osteoporosis at the primary health-care level. Technical Report. Accessible at http://​www.​shef.​ac.​uk/​FRAX/​pdfs/​WHO_​Technical_​Report.​pdf. Published by the University of Sheffield; 2007

Zurück zum Zitat Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O’Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O’Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Crabtree N, Duffy H, Parle J, Rashid F, Stant K, Taylor K, Thomas C, Knox E, Tenneson C, Williams H, Adams D, Bion V, Blacklock J, Dyer T, Bratherton S, Fidler M, Knight K, McGurk C, Smith K, Young S, Collins K, Cushnaghan J, Arundel C, Bell K, Clark L, Collins S, Gardner S, Mitchell N (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391(10122):741–747CrossRef Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O’Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O’Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Crabtree N, Duffy H, Parle J, Rashid F, Stant K, Taylor K, Thomas C, Knox E, Tenneson C, Williams H, Adams D, Bion V, Blacklock J, Dyer T, Bratherton S, Fidler M, Knight K, McGurk C, Smith K, Young S, Collins K, Cushnaghan J, Arundel C, Bell K, Clark L, Collins S, Gardner S, Mitchell N (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391(10122):741–747CrossRef

Zurück zum Zitat McCloskey E, Johansson H, Harvey NC, Shepstone L, Lenaghan E, Fordham R, Harvey I, Howe A, Cooper C, Clarke S, Gittoes N, Heawood A, Holland R, Marshall T, O’Neill TW, Peters TJ, Redmond N, Torgerson D, Kanis JA, the SCOOP Study Team (2018) Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures-a post hoc analysis of the SCOOP study. J Bone Miner Res 33:1020–1026CrossRef McCloskey E, Johansson H, Harvey NC, Shepstone L, Lenaghan E, Fordham R, Harvey I, Howe A, Cooper C, Clarke S, Gittoes N, Heawood A, Holland R, Marshall T, O’Neill TW, Peters TJ, Redmond N, Torgerson D, Kanis JA, the SCOOP Study Team (2018) Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures-a post hoc analysis of the SCOOP study. J Bone Miner Res 33:1020–1026CrossRef

Zurück zum Zitat Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N et al (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395–2411CrossRef Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N et al (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395–2411CrossRef

Zurück zum Zitat Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K (2013) Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 28(8):1701–1717CrossRef Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K (2013) Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 28(8):1701–1717CrossRef

Zurück zum Zitat Morin SN, Lix LM, Leslie WD (2014) The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women. J Bone Miner Res 29(7):1675–1680CrossRef Morin SN, Lix LM, Leslie WD (2014) The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women. J Bone Miner Res 29(7):1675–1680CrossRef

Zurück zum Zitat Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRef Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRef

Zurück zum Zitat Kanis JA, Barton IP, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16(5):475–482CrossRef Kanis JA, Barton IP, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16(5):475–482CrossRef

Zurück zum Zitat Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19(10):1431–1444CrossRef Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19(10):1431–1444CrossRef

Zurück zum Zitat Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2007) Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 18(8):1109–1117CrossRef Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2007) Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 18(8):1109–1117CrossRef

Zurück zum Zitat Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P et al (2011) Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res 26(10):2411–2418CrossRef Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P et al (2011) Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res 26(10):2411–2418CrossRef

Zurück zum Zitat Mackey DC, Lui LY, Cawthon PM, Bauer DC, Nevitt MC, Cauley JA, Hillier TA, Lewis CE, Barrett-Connor E, Cummings SR, Study of Osteoporotic Fractures (SOF) and Osteoporotic Fractures in Men Study (MrOS) Research Groups (2007) High-trauma fractures and low bone mineral density in older women and men. JAMA 298(20):2381–2388CrossRef Mackey DC, Lui LY, Cawthon PM, Bauer DC, Nevitt MC, Cauley JA, Hillier TA, Lewis CE, Barrett-Connor E, Cummings SR, Study of Osteoporotic Fractures (SOF) and Osteoporotic Fractures in Men Study (MrOS) Research Groups (2007) High-trauma fractures and low bone mineral density in older women and men. JAMA 298(20):2381–2388CrossRef

Zurück zum Zitat Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E et al (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780CrossRef Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E et al (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780CrossRef

Zurück zum Zitat Giangregorio LM, Leslie WD, Manitoba Bone Density P (2010) Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res 25(6):1400–1405CrossRef Giangregorio LM, Leslie WD, Manitoba Bone Density P (2010) Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res 25(6):1400–1405CrossRef

Zurück zum Zitat Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28(6):1765–1769CrossRef Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28(6):1765–1769CrossRef

Zurück zum Zitat Leslie WD, Manitoba Bone Density Program C (2008) Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int 19(4):459–463CrossRef Leslie WD, Manitoba Bone Density Program C (2008) Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int 19(4):459–463CrossRef

Zurück zum Zitat Leslie WD, Morin S, Lix LM (2010) A before-and-after study of fracture risk reporting and osteoporosis treatment initiation. Ann Intern Med 153(9):580–586CrossRef Leslie WD, Morin S, Lix LM (2010) A before-and-after study of fracture risk reporting and osteoporosis treatment initiation. Ann Intern Med 153(9):580–586CrossRef

Zurück zum Zitat Leslie WD, Seeman E, Morin SN, Lix LM, Majumdar SR (2018) The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: a registry-based cohort study. Bone 114:298–303CrossRef Leslie WD, Seeman E, Morin SN, Lix LM, Majumdar SR (2018) The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: a registry-based cohort study. Bone 114:298–303CrossRef